MYL

Mylan N.V. Press Releases

$55.99
*  
0.36
0.64%
Get MYL Alerts
*Delayed - data as of Jul. 31, 2015  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo
7/29/2015 7:00:00 AM - PR Newswire
▼-0.48 % Price Change since this news event. The Volume Ratio is 2.61.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders
7/27/2015 3:58:00 PM - PR Newswire
▼-0.73 % Price Change since this news event. The Volume Ratio is 7.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Comments on Teva''s Agreement to Acquire Allergan''s Generic Drug Unit
7/27/2015 6:42:00 AM - PR Newswire
▼-3.95 % Price Change since this news event. The Volume Ratio is 8.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Teva Withdraws Proposal to Acquire Mylan
7/27/2015 4:31:00 AM - Business Wire


Mylan Schedules Second Quarter 2015 Financial Results Conference Call and Live Webcast
7/24/2015 3:28:00 PM - PR Newswire
▼-14.62 % Price Change since this news event. The Volume Ratio is 3.18.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Acknowledges Exercise of Full Call Option by the Independent Foundation
7/23/2015 8:47:00 AM - PR Newswire
▼-16.43 % Price Change since this news event. The Volume Ratio is 1.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Mylan One of First to Launch Generic Version of Namenda® Tablets
7/14/2015 7:30:00 AM - PR Newswire
▼-21.42 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches First Generic Targretin® Capsules
7/9/2015 7:30:00 AM - PR Newswire
▼-18.86 % Price Change since this news event. The Volume Ratio is 1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






U.S. Court of Appeals for the Federal Circuit Finds Teva's '808 Copaxone® Patent Invalid
6/18/2015 11:55:00 AM - PR Newswire
▼-22.06 % Price Change since this news event. The Volume Ratio is 1.7.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Mylan Issues Statement in Response to Abbott''s Support for Perrigo Transaction
6/16/2015 9:19:00 AM - PR Newswire
▼-22.72 % Price Change since this news event. The Volume Ratio is 3.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy Seretide® Evohaler® (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla™ in the UK
6/8/2015 3:00:00 AM - PR Newswire
▼-24.34 % Price Change since this news event. The Volume Ratio is 2.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan to Present at Goldman Sachs 36th Annual Global Healthcare Conference
6/3/2015 11:00:00 AM - PR Newswire
▼-23.20 % Price Change since this news event. The Volume Ratio is 1.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches Generic Version of Seasonique® Tablets
6/2/2015 3:50:00 PM - PR Newswire
▼-22.59 % Price Change since this news event. The Volume Ratio is 0.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan Launches Generic INTUNIV® Tablets
6/2/2015 3:30:00 PM - PR Newswire
▼-22.79 % Price Change since this news event. The Volume Ratio is 33.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan to Present at the Bernstein Strategic Decisions Conference
5/26/2015 4:48:00 PM - PR Newswire
▼-20.64 % Price Change since this news event. The Volume Ratio is 2.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan/Perrigo Clarification
5/25/2015 9:47:00 AM - PR Newswire
▼-19.79 % Price Change since this news event. The Volume Ratio is 1.48.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Mylan to Present at the UBS Global Healthcare Conference
5/12/2015 4:00:00 PM - PR Newswire
▼-20.39 % Price Change since this news event. The Volume Ratio is 1.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Mylan to Present at the Bank of America Merrill Lynch Health Care Conference
5/12/2015 7:30:00 AM - PR Newswire
▼-22.76 % Price Change since this news event. The Volume Ratio is 1.07.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day